Mob.:
+86 156 3115 5652
Mob.:
+86 156 3115 5652
E-mail:
thinkdo_calvin@126.com/thinkdochem@126.com
Mob.:
+86 156 3115 5652
Mob.:
+86 156 3115 5652
E-mail:
thinkdo_calvin@126.com/thinkdochem@126.com
News
HPMA, commonly defined in water treatment as hydrolyzed polymaleic anhydride, is a low-molecular-weight, water-soluble polymer used to control mineral deposits in industrial water systems. In this guide, I explain HPMA for Scale Control: Application and Dosage Considerations, including how the polymer works, where it is used, how to estimate feed rates, and why final dosage must be validated against water chemistry. The acronym HPMA can also appear in biomedical contexts, so this article focuses only on the industrial water treatment polymer.
HPMA controls scale through crystal distortion, threshold inhibition, particle dispersion, and interference with crystal growth.
Initial HPMA dosage depends on hardness, alkalinity, pH, temperature, residence time, and concentration ratio.
Cooling water commonly requires lower active-polymer doses than high-temperature or heavily concentrated systems.
Commercial product concentration must be converted into active-polymer feed rate before setting a metering-pump output.
HPMA can complement phosphonates, polyacrylates, PESA, PBTC, and corrosion inhibitors in blended treatment programs.
Laboratory inhibition results do not automatically predict field performance without pilot testing and monitoring.
HPMA is a water-soluble polymer containing multiple carboxyl functional groups that interact with dissolved hardness ions and developing mineral crystals. Its main purpose is to prevent calcium carbonate and related deposits from forming compact, adherent layers on heat-transfer surfaces, pipelines, membranes, and process equipment. Commercial names may include hydrolyzed polymaleic anhydride, polymaleic acid, or closely related polymaleate products, so I always confirm the chemical identity and specification sheet before comparing products.
HPMA is not the same as PESA, polyacrylic acid, or a phosphonate scale inhibitor. These materials may serve similar functions, but their molecular structures, thermal behavior, biodegradation profiles, compatibility, and effective dosage ranges can differ. A technical data sheet should identify the active content, pH, density, appearance, storage conditions, and recommended application range.
Think-Do Chemicals identifies its HPMA product as a low-molecular-weight polymeric electrolyte supplied as a clear to amber aqueous solution. The listed specification includes approximately 48–52% solid content, a 1% solution pH of 2.0–3.0, and a density of at least 1.18 g/cm³ at 20°C. Its product information also describes thermal stability up to approximately 330°C, although actual service performance depends on exposure time, pressure, oxygen level, water chemistry, and the presence of other treatment chemicals.
HPMA works through several related mechanisms rather than one permanent chemical reaction. First, polymer molecules adsorb onto active sites on developing crystals, changing the way ions arrange themselves in the crystal lattice. This crystal-lattice distortion produces smaller, less regular particles that are less likely to form a hard deposit.
Second, HPMA provides threshold inhibition. A relatively small concentration can interfere with precipitation beyond the amount that would be expected from a simple one-to-one reaction with calcium ions. The polymer also supports dispersion by keeping fine particles suspended, allowing them to leave the system through blowdown, filtration, or water movement instead of attaching to equipment surfaces.
Third, HPMA interferes with crystal growth and can reduce the formation of dense calcium carbonate structures. This does not mean that every mineral scale will respond equally. Calcium carbonate is often a suitable target, while calcium sulfate, silica, barium sulfate, and mixed deposits may require a different polymer, a blended program, pretreatment, or a separate cleaning strategy.
In practical terms, HPMA attaches to growing mineral surfaces, disrupts normal crystal growth, and disperses the resulting particles. Its effectiveness depends on whether the polymer reaches the precipitation zone before the scale-forming ions become highly supersaturated. Feed-point location, residence time, mixing quality, and continuous dosing therefore matter as much as the nominal ppm value.
The table below gives initial screening ranges expressed as active polymer. These are not universal operating limits; they are starting points for laboratory testing, pilot work, or controlled field optimization. The final dose should be based on scale type, saturation conditions, water turnover, operating temperature, and actual deposit monitoring.
| Application | Indicative HPMA dose as active polymer | Main dosage drivers |
|---|---|---|
| Open recirculating cooling water | 2–10 mg/L | Hardness, alkalinity, pH, cycles of concentration, temperature |
| Closed cooling systems | 1–5 mg/L | Make-up quality, corrosion program, retention time |
| Boiler water treatment | 1–10 mg/L | Pressure, feedwater hardness, phosphate program, blowdown |
| RO pretreatment or membrane feed | 1–5 mg/L | Recovery, calcium sulfate risk, silica, iron, membrane compatibility |
| MED or MSF desalination | 2–10 mg/L | Brine concentration, temperature, residence time, target mineral |
| Oilfield injection water | 5–20 mg/L | Salinity, barium or strontium, temperature, formation compatibility |
| Evaporation and high-temperature systems | 5–30 mg/L | Thermal load, concentration factor, retention time, scale saturation |
I determine dosage by evaluating the water chemistry and process conditions together. The key variables are calcium hardness, magnesium hardness, alkalinity, sulfate, silica, iron, aluminum, pH, conductivity, temperature, pressure, concentration ratio, and the target scale. A system with moderate hardness but a high concentration factor may need more treatment than a once-through system with higher incoming hardness.
Residence time is also important. Short-contact systems need effective distribution before precipitation begins, while long-retention systems may allow more time for crystal-growth interference. For cooling water, I also review cycles of concentration and blowdown frequency because both determine how quickly dissolved minerals accumulate.
Commercial HPMA products are usually supplied as concentrated aqueous solutions rather than 100% active polymer. To calculate the required product dose, divide the target active concentration by the active fraction of the commercial product. For example, if the target is 5 mg/L active HPMA and the product contains 50% solids, the approximate product dose is 10 mg/L as supplied.
The daily product requirement can then be estimated using the system flow:
Product feed, kg/day = product dose, mg/L × water flow, m³/day ÷ 1,000
Using the previous example, a system processing 500 m³/day at 10 mg/L as supplied would require approximately 5 kg/day of product. I would still correct the calculation for the supplier’s declared active basis, density, pump calibration, dilution water, and actual operating flow.
A metering pump should be calibrated by measuring delivered volume over a known period rather than relying only on the pump dial. If the product is diluted, the dilution ratio must be included in the calculation. The feed solution should remain homogeneous, and the injection point should provide rapid mixing without exposing the polymer to incompatible concentrated chemicals.
For HPMA for cooling water treatment, I begin with the makeup-water analysis and expected cycles of concentration. Calcium hardness, alkalinity, pH, temperature, and conductivity determine the likelihood of calcium carbonate precipitation, while sulfate and silica may create additional risks. Open cooling towers often start within the 2–10 mg/L active range, then adjust according to heat-exchanger inspection, conductivity control, and deposit coupons.
HPMA should be fed continuously rather than added as an occasional shock dose when the objective is ongoing scale prevention. The product may be combined with corrosion inhibitors, biocides, phosphonates, or dispersants, but compatibility must be checked because concentrated blends can produce haze, precipitation, or viscosity changes. I would review the system after one to three operating cycles before making a major dosage change.
Boiler applications require careful control because temperature and concentration increase the rate of precipitation. HPMA can support hardness dispersion and deposit control, but it does not replace softening, dealkalization, condensate management, or a complete boiler-water program. The suitable dose depends on boiler pressure, feedwater hardness, phosphate chemistry, blowdown rate, and whether the program targets internal treatment or external pretreatment.
In low- to moderate-pressure systems, an initial active dose of 1–10 mg/L may be evaluated. Higher-pressure systems require a more conservative review because thermal stability, impurity concentration, and chemical compatibility become more important. I would not select a boiler dose from a generic table without checking the operating pressure and the complete treatment formulation.
In MED and MSF desalination, HPMA may be evaluated for carbonate and selected sulfate-control duties where temperature and brine concentration are significant. The product must be tested against the actual feedwater because mineral saturation changes as water passes through heaters, evaporators, and brine circuits. A polymer that performs well in a cooling tower may not provide the same protection in a high-temperature desalination process.
For RO pretreatment, the central concerns are recovery, membrane type, calcium sulfate risk, silica, iron, aluminum, and the compatibility requirements of the membrane manufacturer. Typical starting doses may fall near 1–5 mg/L active, but a lower or higher value may be appropriate depending on recovery and feedwater chemistry. Membrane-feed testing should include normalized permeate flow, salt passage, pressure drop, and evidence of fouling.
Oilfield injection water may contain high salinity, sulfate, barium, strontium, iron, and suspended solids. HPMA may assist with deposit control, but the product must be evaluated against the formation mineralogy and water-mixing conditions. Incompatibility between injection water and formation water can cause precipitation that a standard calcium carbonate test will not predict.
Evaporation systems and other high-temperature processes usually require attention to residence time and concentration factor. An initial active range of 5–30 mg/L may be screened for severe conditions, but thermal exposure can change polymer performance over time. Sampling before and after the hottest process zone can show whether the treatment remains chemically available where scale control is needed.
HPMA is best evaluated as part of a treatment selection matrix rather than as a universal replacement for every inhibitor. The following comparison describes typical positioning; actual results depend on formulation, water chemistry, and test method.
| Treatment chemistry | Main strength | Main limitation | Typical selection context |
|---|---|---|---|
| HPMA | Crystal distortion and dispersion, with useful thermal tolerance | May require blending for difficult sulfate, silica, or corrosion conditions | Cooling water, boilers, evaporation, industrial process water |
| Phosphonates | Strong threshold inhibition and metal-ion control | Adds phosphorus and may have precipitation or regulatory concerns | Cooling and industrial systems needing calcium control |
| Polyacrylic acid or PAA | Dispersion of suspended mineral particles | Performance can vary with molecular weight and hardness | Dispersant-focused programs and blended formulations |
| PESA | Phosphorus-free alternative with scale and dispersion functions | Not chemically identical to HPMA; testing is required | Formulations seeking phosphorus reduction |
| PBTC | Good performance in some high-hardness and high-temperature systems | Higher product cost or formulation-specific compatibility | Severe cooling and industrial water conditions |
| Blended inhibitor program | Combines complementary scale, corrosion, and dispersion functions | More complex dosing and compatibility control | Large systems with several deposit and corrosion risks |
Compared with phosphonates, HPMA may be selected when a low-phosphorus or phosphorus-free approach is preferred, but the decision should include corrosion control and environmental discharge requirements. Compared with PAA, HPMA may provide stronger crystal-growth interference in some systems, while PAA can be useful when particle dispersion is the main requirement. PESA and PBTC should be assessed through the same water-specific test protocol rather than assumed to be direct substitutes.
| Observed problem | Likely causes | Corrective actions |
|---|---|---|
| Hard calcium carbonate deposits | Underdosing, poor mixing, excessive cycles, high pH | Verify pump output, test active dose, review blowdown and alkalinity |
| Suspended haze or gel formation | Overdosing, concentrated chemical contact, incompatible blend | Dilute correctly, separate feed points, perform jar compatibility tests |
| Scale appears despite normal pump settings | Empty tank, blocked line, poor calibration, wrong active-content assumption | Measure actual delivery, inspect injection equipment, recalculate product dose |
| Performance drops at high temperature | Thermal exposure, long residence time, unsuitable product selection | Conduct hot-loop testing and compare HPMA with PBTC or a blended program |
| Iron or aluminum deposits increase | Upstream corrosion, coagulant carryover, insufficient dispersion | Control metal sources, improve filtration, test compatibility with the full program |
| Calcium phosphate or sulfate remains uncontrolled | Target scale differs from the tested mineral | Run mineral-specific screening and consider a complementary inhibitor |
Overdosing is not automatically safer. Excess polymer can increase operating cost, contribute to organic load, interfere with other chemicals, or produce dispersion problems that complicate filtration. Underdosing is more common when the feed pump is calibrated for product volume but the calculation was made using active-polymer concentration.
I recommend a staged validation process before selecting a permanent feed rate. First, analyze representative makeup, recirculating, concentrate, or injection water samples. Second, identify the main target scale using deposit analysis, saturation calculations, or mineral testing rather than assuming every white deposit is calcium carbonate.
Next, compare at least three active-polymer concentrations around the proposed operating point. For example, a cooling-water study might test 2, 5, and 8 mg/L active, while a severe evaporation system might require a wider range. Measure turbidity, particle size, deposit mass, filterability, and residual active polymer where a suitable analytical method is available.
After laboratory work, use a pilot loop or controlled plant trial. Record pH, conductivity, hardness, alkalinity, temperature, cycles of concentration, blowdown, flow, pump output, heat-transfer performance, and inspection results. Laboratory inhibition percentages are useful for ranking products, but they should not be presented as direct predictions of field performance.
| If your priority is... | Evaluation focus |
|---|---|
| Calcium carbonate control in cooling water | Carbonate saturation, pH, cycles of concentration, continuous feed stability |
| High-temperature operation | Thermal aging, residence time, product stability, deposit analysis |
| RO pretreatment | Membrane compatibility, recovery, sulfate and silica risk, fouling indicators |
| Boiler treatment | Pressure, feedwater hardness, phosphate compatibility, blowdown control |
| Oilfield injection water | Formation compatibility, barium and strontium control, salinity, filtration |
| Reduced phosphorus discharge | HPMA, PESA, PAA, PBTC, and blended phosphorus-free options |
| Lowest total treatment cost | Product price, active concentration, feed rate, cleaning frequency, downtime |
I also review the supplier’s technical data sheet, batch consistency, packaging, storage conditions, sample availability, and technical support. Think-Do Chemicals presents HPMA as part of its industrial water treatment portfolio and reports product specifications including solid content, pH, density, and application as a scale inhibitor and dispersant. Those details are useful for initial screening, but each buyer should request a current specification and test sample for the intended water system.
HPMA for Scale Control: Application and Dosage Considerations should be treated as a water-chemistry and process-design problem, not as a fixed ppm recommendation. HPMA can control mineral deposits through crystal distortion, threshold inhibition, dispersion, and crystal-growth interference, particularly when the target scale, feed point, and operating conditions are properly matched.
My recommended next step is to establish the active-polymer basis, calculate the product feed rate, and test at least three dosage levels using representative system water. Then confirm performance through monitoring of hardness, alkalinity, pH, conductivity, cycles of concentration, temperature, deposit formation, and equipment performance. For cooling towers, boilers, desalination, RO pretreatment, oilfield injection water, and high-temperature evaporation, the correct HPMA dose must be optimized against the actual scale risk and the complete chemical program.
